About the UP-AA Study
The UP-AA Study is a clinical research study designed to evaluate the safety and efficacy of an investigational drug compared to a placebo in achieving hair regrowth and improving the quality of life for participants living with alopecia areata. Participants receive either the investigational drug or a placebo (something that looks like the investigational drug but has no effect on the body), both administered orally (by mouth).
This research study will last up to 160 weeks (about 3 years). Participants will be randomly assigned to receive either the investigational drug or a placebo. After the first 24 weeks (about 6 months) of this study treatment period, some participants will continue to receive their assigned study drug (investigational or placebo) for another 28 weeks (about 7 months) while some participants receiving the placebo will be randomly assigned to receive the investigational drug. After the end of this second period, some participants will continue to receive their treatment and some participants receiving the investigational drug will be given a different dosage of the investigational drug for the next 108 weeks (about 2 years) of the study.
